Patients
We performed a retrospective review of patients undergoing aortic cusp extension valvuloplasty at a large, urban academic medical center between April 2009 to July 2016. Patients receiving CorMatrix, either patch or membrane, were compared to those receiving autologous pericardium irrespective of glutaraldehyde time.